Global HIV response at risk as funding cuts raise fears of epidemic resurgence
|
Reductions in international funding and cuts to HIV
prevention and community services are likely to lead to a resurgence of the HIV
epidemic, ... |
BioNTech Launches mRNA HIV Vaccine Trial
... antiretroviral therapy for at least 12 months will receive four injections. Enrollment will span participants aged 18 to 50 years; those with HIV ... View article...